Financhill
Buy
81

NHYDY Quote, Financials, Valuation and Earnings

Last price:
$7.84
Seasonality move :
8.11%
Day range:
$7.65 - $7.89
52-week range:
$4.50 - $7.89
Dividend yield:
2.77%
P/E ratio:
15.13x
P/S ratio:
0.76x
P/B ratio:
1.52x
Volume:
29.5K
Avg. volume:
76.2K
1-year change:
42.65%
Market cap:
$15.4B
Revenue:
$18.9B
EPS (TTM):
$0.52

Earnings Data

Next earnings date for NHYDY
Feb 13
2026
Most recent earnings per share
$0.11
Beat by $0.03
(Oct 24/2025)
Consensus Estimate
$0.08
(Oct 24/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

NHYDY Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
02/13/2026 Q4 $4.7B -- -- -- --
10/24/2025 Q3 $4.7B $5B $0.11 $0.08 $0.03
07/22/2025 Q2 $5.1B $5.1B $0.10 $0.08 $0.02
04/29/2025 Q1 $5.6B $5.3B $0.22 $0.20 $0.02
02/14/2025 Q4 $4.6B $4.9B $0.09 $0.23 -$0.14
10/24/2024 Q3 $4.7B $4.6B $0.04 $0.14 -$0.10
07/23/2024 Q2 $4.6B $4.7B $0.10 $0.14 -$0.04
04/24/2024 Q1 $4.4B $4.5B $0.04 $0.09 -$0.05
02/14/2024 Q4 $4B $4.2B -$0.12 $0.06 -$0.18
10/24/2023 Q3 -- $4.1B -$0.02 -- --
07/21/2023 Q2 -- $5.3B $0.24 -- --
04/28/2023 Q1 -- $4.7B $0.06 -- --
02/14/2023 Q4 -- $4.3B $0.01 -- --
10/25/2022 Q3 -- $5.4B $0.33 -- --
07/22/2022 Q2 -- $7.6B $0.58 -- --
05/03/2022 Q1 -- $4.8B $0.32 -- --
02/22/2022 Q4 -- $5.2B $0.40 -- --
10/26/2021 Q3 -- $3.8B $0.06 -- --
07/23/2021 Q2 -- $3.9B $0.15 -- --
04/27/2021 Q1 -- $3.9B $0.08 -- --
02/12/2021 Q4 -- $3.2B $0.28 -- --
10/23/2020 Q3 -- $3.1B -$0.01 -- --
07/22/2020 Q2 -- $2.5B -$0.06 -- --
04/29/2020 Q1 -- $3.3B -$0.09 -- --
02/07/2020 Q4 -- $3.9B -$0.03 -- --
10/23/2019 Q3 -- $4.2B -$0.07 -- --
07/23/2019 Q2 -- $4.5B -$0.00 -- --
06/05/2019 Q1 -- $4.4B $0.00 -- --
02/07/2019 Q4 -- $4.5B -$0.04 -- --
10/24/2018 Q3 -- $4.8B $0.04 -- --
07/24/2018 Q2 -- $5.1B $0.13 -- --
04/25/2018 Q1 -- $5.1B $0.13 -- --
02/16/2018 Q4 -- $4.8B $0.21 -- --
10/25/2017 Q3 -- $2.9B $0.13 -- --
07/25/2017 Q2 -- $2.9B $0.09 -- --
04/28/2017 Q1 -- $2.7B $0.10 -- --
02/09/2017 Q4 -- $2.5B $0.06 -- --
10/25/2016 Q3 -- $2.4B $0.06 -- --
07/21/2016 Q2 -- $2.5B $0.12 -- --
04/27/2016 Q1 -- $2.3B $0.13 -- --
02/17/2016 Q4 -- $2.4B $0.03 -- --

Norsk Hydro ASA Earnings Questions

  • How Much did Norsk Hydro ASA Generate in Revenue Last Quarter?

    Norsk Hydro ASA reported $5B worth of top line sales in its most recent quarter.

  • Did Norsk Hydro ASA Beat Earnings Last Quarter?

    Norsk Hydro ASA announced earnings per share of $0.11 which represents a beat of analyst forecast a $0.08 per share.

  • Is Norsk Hydro ASA Profitable?

    Norsk Hydro ASA reported $853.1M that represents $0.43 per share over the last quarter.

  • What is the Analyst Consensus for Norsk Hydro ASA EPS Next Year?

    Norsk Hydro ASA's earnings are forecast to grow from $0.27 per share to $0.52 per share next year representing an increase of 86.39%.

  • When is Norsk Hydro ASA's Earnings Date?

    Norsk Hydro ASA's next earnings date is February 13, 2026.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is DocuSign Stock Undervalued?
Is DocuSign Stock Undervalued?

Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…

Is SentinelOne Stock Undervalued?
Is SentinelOne Stock Undervalued?

Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…

Is Broadcom Stock on Sale?
Is Broadcom Stock on Sale?

Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…

Stock Ideas

Buy
59
Is NVDA Stock a Buy?

Market Cap: $4.6T
P/E Ratio: 64x

Buy
55
Is AAPL Stock a Buy?

Market Cap: $4T
P/E Ratio: 37x

Buy
61
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 39x

Alerts

Buy
85
HUT alert for Dec 25

Hut 8 Corp. [HUT] is up 0.65% over the past day.

Buy
80
TVTX alert for Dec 25

Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.

Buy
63
GPCR alert for Dec 25

Structure Therapeutics, Inc. [GPCR] is down 2.36% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock